首页> 外文期刊>BMC Urology >Three-dimensional greyscale transrectal ultrasound-guidance and biopsy core preembedding for detection of prostate cancer: Dutch clinical cohort study
【24h】

Three-dimensional greyscale transrectal ultrasound-guidance and biopsy core preembedding for detection of prostate cancer: Dutch clinical cohort study

机译:三维灰度经直肠超声引导和活检核心预埋检测前列腺癌:荷兰临床队列研究

获取原文
           

摘要

To overcome the limitations regarding two dimensional (2D) greyscale (GS) transrectal ultrasound (TRUS)-guided biopsy in prostate cancer (PCa) detection and tissue packaging in biopsy processing, there is an ongoing focus on new imaging and pathology techniques. A three-dimensional (3D) model of the prostate with biopsy needle guidance can be generate by the Navigo? workstation (UC-care, Israel). The SmartBX? system (UC-care, Israel) provides a prostate biopsy core preembedding method. The aim of this study was to compare cancer detection rates between the 3D TRUS-guidance and preembedding method with conventional 2D GS TRUS-guidance among patients undergoing prostate biopsies. We retrospectively analyzed the records of all patients who underwent prostate biopsies for PCa detection at our institution from 2007 to 2016. The cohort was divided into a 2D GS TRUS-guidance cohort (from 2007 to 2013, n?=?1149) and a 3D GS TRUS-guidance with preembedding cohort (from 2013 to 2016, n?=?469). Effect of 3D GS TRUS-guidance with preembedding on detection rate of PCa and clinically significant PCa (Gleason score?≥?7 or??2 biopsy cores with a Gleason score 6) was compared to 2D GS TRUS-guidance using regression models. Detection rate of PCa and clinically significant PCa was 39.0 and 24.9% in the 3D GS TRUS cohort compared to 33.5 and 19.0% in the 2D GS TRUS cohort, respectively. On multivariate regression analysis the use of 3D GS TRUS-guidance with preembedding was associated with a significant increase in detection rate of PCa (aOR?=?1.33; 95% CI: 1.03–1.72) and clinically significant PCa (aOR?=?1.47; 95% CI: 1.09–1.98). Our results suggest that 3D GS TRUS-guidance with biopsy core preembedding improves PCa and clinically significant PCa detection compared to 2D GS TRUS-guidance. Additional studies are needed to justify the application of these systems in clinical practice.
机译:为了克服二维(2D)灰度(GS)经直肠超声(TRUS)引导的活检在前列腺癌(PCa)检测和活检处理中的组织包装方面的局限性,我们一直在关注新的成像和病理学技术。 Navigo?可以生成带有活检针引导的前列腺三维(3D)模型。工作站(UC-care,以色列)。 SmartBX?系统(UC-care,以色列)提供了一种前列腺活检核心预埋方法。这项研究的目的是比较前列腺活检患者中3D TRUS指导和预埋方法与常规2D GS TRUS指导之间的癌症检出率。我们回顾性分析了我们机构从2007年至2016年接受前列腺活检以进行PCa检测的所有患者的记录。该队列分为2D GS TRUS指导队列(从2007年至2013,n?=?1149)和3D GS TRUS指导与预嵌入队列(从2013年到2016年,n?=?469)。使用回归模型,将预先嵌入的3D GS TRUS指导对PCa和临床上显着的PCa(格里森评分≥7或≥2个活检核心,格里森评分6)的检出率与2D GS TRUS指导的回归模型进行比较。在3D GS TRUS队列中,PCa和具有临床意义的PCa检出率分别为39.0和24.9%,而在2D GS TRUS队列中,分别为33.5和19.0%。在多元回归分析中,将3D GS TRUS指导与预嵌入一起使用可显着提高PCa的检出率(aOR?=?1.33; 95%CI:1.03-1.72)和临床上显着的PCa(aOR?=?1.47) ; 95%CI:1.09–1.98)。我们的结果表明,与2D GS TRUS指南相比,带有活检核心预埋的3D GS TRUS指南可改善PCa和临床上重要的PCa检测。需要进一步的研究来证明这些系统在临床实践中的合理性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号